Valeant Pharmaceuticals Intl (VRX) 22.36 $VRX Downtrend

New Post Public Reply Private Reply Replies (0) Message Board

Aug 3, 2016 at 11:07 PM

Valeant Pharmaceuticals Intl (VRX) 22.36 $VRX

Downtrend Call Working As Valeant Pharmaceuticals International Stock Falls 25.5% (VRX)
Comtex SmarTrend(R) - Wed Aug 03, 12:57PM CDT
SmarTrend identified a Downtrend for Valeant Pharmaceuticals International (NYSE:VRX) on May 9th, 2016 at $29.49. In approximately 3 months, Valeant Pharmaceuticals International has returned 25.51% as of today's recent price of $21.97.
VRX: 22.36 (+1.19)

Research Report on These Healthcare Sector Equities -- Valeant Pharma, Pernix Therapeutics, Perrigo, and Lipocine
PR Newswire - Mon Aug 01, 6:35AM CDT
The number of individuals who require medical attention and treatment is constantly growing, which is why Healthcare stocks remain in high demand. Earnings growth potential within the healthcare sector is much higher compared with other sectors, opening long-term opportunities for investors. Stock-Callers.com reviews the following equities: Valeant Pharmaceuticals International Inc. (NYSE: VRX), Pernix Therapeutics Holdings Inc. (NASDAQ: PTX), Perrigo Co. PLC (NYSE: PRGO), and Lipocine Inc. (NASDAQ: LPCN). Learn more about these stocks by accessing their free research reports at:
PRGO: 94.25 (+2.64), VRX: 22.36 (+1.19), PTX: 0.68 (-0.19), LPCN: 3.59 (+0.19), VRX.TO: 29.21 (+1.48)

Watch for Valeant Pharmaceuticals International to Potentially Rebound After Falling 2.53% Yesterday
Comtex SmarTrend(R) - Fri Jul 29, 1:03PM CDT
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $22.32 to a high of $23.06. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $22.55 on volume of 6.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRX: 22.36 (+1.19)

Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
PR Newswire - Thu Jul 28, 4:00PM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve as a director of the Board, effective July 22, 2016. With these changes, Valeant has increased the size of its board to 12 members, 11 of whom are independent.
VRX: 22.36 (+1.19), VRX.TO: 29.21 (+1.48)

InvestorsObserver releases covered-call reports for Valeant Pharmaceuticals, Potash Corporation of Saskatchewan, Barrick Gold Corporation, Teva and Monsanto Company
PR Newswire - Thu Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ABX, MON, POT, TEVA, and VRX.
VRX: 22.36 (+1.19), MON: 104.36 (-1.26), ABX: 22.42 (-0.27), POT: 15.81 (-0.04), TEVA: 53.57 (+0.61)

Pharming Reports on Financial Results for the First Six Months of 2016
PR Newswire Europe - Thu Jul 28, 12:01AM CDT
LEIDEN, The Netherlands, July 28, 2016 /PRNewswire/ --
VRX: 22.36 (+1.19), VRX.TO: 29.21 (+1.48)

Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 5:49PM CDT
Valeant Pharmaceuticals International, Inc.'s (VRX) Biologic License Application (BLA) for brodalumab is up for review by an FDA panel.
VRX: 22.36 (+1.19), AZN: 34.09 (-0.12), AMGN: 173.43 (-0.72), BMY: 74.80 (-0.25)

Pharming Announces Positive Results from Randomized Controlled Trial with RUCONEST® for HAE Prophylaxis
PR Newswire Europe - Mon Jul 18, 12:01AM CDT
LEIDEN, The Netherlands, July 18, 2016 /PRNewswire/ --
VRX: 22.36 (+1.19), VRX.TO: 29.21 (+1.48)

Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details
CNW Group - Fri Jul 15, 7:00AM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on August 9, 2016 to discuss second quarter 2016 financial results.
VRX: 22.36 (+1.19), VRX.TO: 29.21 (+1.48)

Company News for July 14, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 9:10AM CDT
Companies In The News are: VRX,TEVA,NOK,HCSG
VRX: 22.36 (+1.19), TEVA: 53.57 (+0.61), HCSG: 38.66 (+0.10), NOK: 5.69 (+0.08)

Casella Waste, Valeant Pharma, Yum Brands and CSX highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 8:30AM CDT
Casella Waste, Valeant Pharma, Yum Brands and CSX highlighted as Zacks Bull and Bear of the Day
VRX: 22.36 (+1.19), CWST: 9.44 (-0.02), CSX: 28.20 (+0.54), YUM: 88.37 (+0.06)

Valeant Pharmaceuticals Comments On Recent Stock Transactions
CNW Group - Thu Jul 14, 7:50AM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the 'Company"

today commented on recent stock transactions made by Valeant's former chief executive officer, J. Michael Pearson. The Company understands that Mr. Pearson exercised and sold options representing approximately 4.4 million shares, which would expire within the next 12 months, and sold approximately 411,000 shares of common stock in June and July to satisfy tax obligations with respect to the 2015 margin sale conducted by Goldman Sachs, and for additional liquidity. Mr. Pearson remains a significant Valeant shareholder with more than 3.5 million shares and is required to hold 1 million shares for two years following employment termination.
VRX: 22.36 (+1.19), VRX.TO: 29.21 (+1.48)

Bear of the Day: Valeant Pharma (VRX)
Brian Hamilton - Zacks Investment Research - Thu Jul 14, 6:01AM CDT
Bear of the Day: Valeant Pharma (VRX)
ZTS: 51.21 (+1.49), VRX: 22.36 (+1.19), MDWD: 7.29 (+0.57)

PHARMING Amends RUCONEST Distribution Agreement with SOBI
PR Newswire Europe - Thu Jul 14, 12:00AM CDT
LEIDEN, the Netherlands, July 14, 2016 /PRNewswire/ --
VRX: 22.36 (+1.19), VRX.TO: 29.21 (+1.48)

Valeant Pharmaceuticals International Rises 3.01% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jul 13, 11:45AM CDT
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $23.41 to a high of $24.67. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $23.90 on volume of 27.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRX: 22.36 (+1.19)

SmarTrend Watching for Potential Pullback in Shares of Valeant Pharmaceuticals International After 9.87% Gain
Comtex SmarTrend(R) - Wed Jul 06, 11:50AM CDT
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $19.61 to a high of $21.93. Yesterday, the shares gained 9.9%, which took the trading range above the 3-day high of $21.65 on volume of 20.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRX: 22.36 (+1.19)

Valeant (VRX) Loses European Rights to Psoriasis Candidate
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 9:59AM CDT
Valeant (VRX) announced that its partner AstraZeneca (AZN) has amended the company's license to its pipeline candidate, brodalumab.
VRX: 22.36 (+1.19), UTHR: 124.86 (-0.99), AZN: 34.09 (-0.12)

AstraZeneca Skin Drug, Tralokinumab, Rights Licensed to LEO
Arpita Dutt - Zacks Investment Research - Wed Jul 06, 8:39AM CDT
AstraZeneca (AZN) out-licensed global rights to tralokinumab for skin diseases to LEO Pharma.
AGN: 252.53 (+1.78), VRX: 22.36 (+1.19), AZN: 34.09 (-0.12), AMGN: 173.43 (-0.72)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moore, Schulman & Moore Attorneys Earn Top Honors Again

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

India's Women Apparel Market Grows Amid Innovation

India's Women Apparel Market on the Rise The winds of fashion change are sweeping through India, and the women's apparel market is at the heart of this sartorial hurricane. Set to explode from USD 28,786.82 million in 2024 to USD 45,491.96 million by 2032, this market is turning heads with a compound annual growth rate (CAGR) of 5.21%. What's stirring this pot, you ask?...

Duke Energy Braces for Isaias: Key Prep Steps Ahead

Brace Yourself: Duke Energy Gears Up for Isaias In the ever-unpredictable game of Mother Nature versus infrastructure, Duke Energy is stepping into the ring once more, readying to tackle potential outages across the Carolinas as Hurricane Isaias edges near. Listen, if there's one thing I've learned over years of watching these weather events unfold on the stock ticker and...

Toyland 2026: Blain's 'Open The Magic' Event Marks 69 Years

There's something about nostalgia that hooks you right in the gut, like remembering those jittery walks through Blain's Farm & Fleet's Toyland aisles. If there's one thing these folks know, it's how to spark holiday cheer deep in the Midwest bones. Here we are, just before the dust settles on another year, and Blain's is rolling out its 69th Toyland party—a cherished...

Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Mastering Packaging Costs: Beyond the Box Price

Peeling Back the Layers of Packaging Costs Packaging's a bit like an onion—every layer you peel back reveals another cost you didn’t see at first glance. Folks in the know, like Kyle Reger of Jamestown Container Companies, are flipping the script on how we approach packaging expenses. It's not just about snagging the cheapest box on the shelf anymore. There's a whole...

Boliden's Q3 2026 Results: What's on the Horizon?

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

CellFiber Expands to Philly: Boosting US Biotech Scene

CellFiber's Leap into 'Cellicon Valley' Folks, when the biotech winds start blowing, you better have your sails up. CellFiber Co., Ltd., a Tokyo-based innovator, has landed itself a comfy spot in the City of Brotherly Love. We're talking Philadelphia, folks, or, as it's dubbed in certain circles, 'Cellicon Valley.' Now if that's not a name that screams biotech pedigree, I...

TKO's Bold $2B All-Cash Move for SVC's Hotels

TKO's Big, Bold Bid: What Does it Mean? In the crazy world of high-stakes hospitality investments, there are moments that turn heads. TKO's $2 billion all-cash offer to snag Service Properties Trust's prized hotel portfolio is exactly one of those shake-ups. Let's not sugarcoat it; this is a bold move to the big leagues, and it's not without its quirks. A Cash-Infused...

DIFF Eyewear Opens First Flagship Store in Charleston

DIFF Eyewear: From Clicks to Bricks in Charleston Here's a tale of a brand shaking things up, jumping from the digital stratosphere right into solid ground. DIFF Eyewear has officially planted its flag in Charleston, SC, marking a bold transition from being an exclusively online player to real-world retail. October 10th rang in their first brick-and-mortar store on...